These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18004405)

  • 1. Scalable human ES culture for therapeutic use: propagation, differentiation, genetic modification and regulatory issues.
    Rao M
    Gene Ther; 2008 Jan; 15(2):82-8. PubMed ID: 18004405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled genetic modification of stem cells for developing drug discovery tools and novel therapeutic applications.
    Zeng X; Rao MS
    Curr Opin Mol Ther; 2008 Jun; 10(3):207-13. PubMed ID: 18535927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human embryonic stem cells: possibilities for human cell transplantation.
    Liew CG; Moore H; Ruban L; Shah N; Cosgrove K; Dunne M; Andrews P
    Ann Med; 2005; 37(7):521-32. PubMed ID: 16278165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic modification of cells for transplantation.
    Lai Y; Drobinskaya I; Kolossov E; Chen C; Linn T
    Adv Drug Deliv Rev; 2008 Jan; 60(2):146-59. PubMed ID: 18037530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review: Stem cells and gene therapy.
    Alenzi FQ; Lotfy M; Tamimi WG; Wyse RK
    Lab Hematol; 2010 Sep; 16(3):53-73. PubMed ID: 20858588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cells as vehicles for therapeutic genes to treat liver diseases.
    Prieto J; Fernandez-Ruiz V; Kawa MP; Sarobe P; Qian C
    Gene Ther; 2008 May; 15(10):765-71. PubMed ID: 18385768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome modification in human embryonic stem cells.
    Tenzen T; Zembowicz F; Cowan CA
    J Cell Physiol; 2010 Feb; 222(2):278-81. PubMed ID: 19877154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lentiviral vector with a short troponin-I promoter for tracking cardiomyocyte differentiation of human embryonic stem cells.
    Gallo P; Grimaldi S; Latronico MV; Bonci D; Pagliuca A; Gallo P; Ausoni S; Peschle C; Condorelli G
    Gene Ther; 2008 Feb; 15(3):161-70. PubMed ID: 18033312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derive and conquer: sourcing and differentiating stem cells for therapeutic applications.
    Klimanskaya I; Rosenthal N; Lanza R
    Nat Rev Drug Discov; 2008 Feb; 7(2):131-42. PubMed ID: 18079756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular genetic therapy.
    Del Vecchio F; Filareto A; Spitalieri P; Sangiuolo F; Novelli G
    Transplant Proc; 2005; 37(6):2657-61. PubMed ID: 16182776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manufacturing considerations for clinical uses of therapies derived from stem cells.
    Weber DJ
    Methods Enzymol; 2006; 420():410-30. PubMed ID: 17161709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera?
    Tonti GA; Mannello F
    Int J Dev Biol; 2008; 52(8):1023-32. PubMed ID: 18956335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of medakafish as a model for stem cell-based gene therapy: efficient gene delivery and potential chromosomal integration by baculoviral vectors.
    Yan Y; Du J; Chen T; Yi M; Li M; Wang S; Li CM; Hong Y
    Exp Cell Res; 2009 Aug; 315(13):2322-31. PubMed ID: 19406120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstituting retroviral (ReCon) vectors facilitating delivery of cytotoxic genes in cancer gene therapy approaches.
    Brandtner EM; Kodajova P; Hlavaty J; Jandl G; Tabotta W; Salmons B; Günzburg WH; Hohenadl C
    J Gene Med; 2008 Feb; 10(2):113-22. PubMed ID: 18076132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Displaced agendas: current regulatory strategies for germline gene therapy.
    Marden E; Nelkin D
    McGill Law J; 2000 May; 45(2):461-81. PubMed ID: 12688283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insertional mutagenesis in gene therapy and stem cell biology.
    Baum C
    Curr Opin Hematol; 2007 Jul; 14(4):337-42. PubMed ID: 17534158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating gene expression in stem cells without recombinant DNA and permanent genetic modification.
    Heng BC; Hong YH; Cao T
    Cell Tissue Res; 2005 Aug; 321(2):147-50. PubMed ID: 15942773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic applications of genetic engineering].
    Descamps JL
    Ann Pharm Fr; 1994; 52(6):294-302. PubMed ID: 7864529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging therapeutic approaches for osteogenesis imperfecta.
    Millington-Ward S; McMahon HP; Farrar GJ
    Trends Mol Med; 2005 Jun; 11(6):299-305. PubMed ID: 15949772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical steps in the implementation of hematopoietic progenitor-cell gene therapy using ribozyme vectors: a laboratory protocol.
    Boyd MP; Ngok FK; Todd AV; Symonds GP; Macpherson JL; Amado RG
    Methods Mol Biol; 2004; 252():599-616. PubMed ID: 15017083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.